These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26144267)

  • 1. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.
    Morello G; Cavallaro S
    Future Med Chem; 2015; 7(10):1335-59. PubMed ID: 26144267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach.
    Morello G; Spampinato AG; Conforti FL; D'Agata V; Cavallaro S
    J Mol Neurosci; 2017 Apr; 61(4):563-580. PubMed ID: 28236105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
    Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
    BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling.
    Morello G; Conforti FL; Parenti R; D'Agata V; Cavallaro S
    Curr Med Chem; 2015; 22(17):2004-21. PubMed ID: 25850769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets.
    Morello G; Spampinato AG; Cavallaro S
    Mediators Inflamm; 2017; 2017():7070469. PubMed ID: 29081603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis.
    Malaspina A; de Belleroche J
    Brain Res Brain Res Rev; 2004 Jul; 45(3):213-29. PubMed ID: 15210305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.
    Rinchetti P; Rizzuti M; Faravelli I; Corti S
    Mol Neurobiol; 2018 Mar; 55(3):2617-2630. PubMed ID: 28421535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic targets for amyotrophic lateral sclerosis.
    Kuzma-Kozakiewicz M; Kwiecinski H
    Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Fukunaga K; Shinoda Y; Tagashira H
    J Pharmacol Sci; 2015 Jan; 127(1):36-41. PubMed ID: 25704016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PACAP and PAC1R are differentially expressed in motor cortex of amyotrophic lateral sclerosis patients and support survival of iPSC-derived motor neurons.
    Bonaventura G; Iemmolo R; D'Amico AG; La Cognata V; Costanzo E; Zappia M; D'Agata V; Conforti FL; Aronica E; Cavallaro S
    J Cell Physiol; 2018 Apr; 233(4):3343-3351. PubMed ID: 28926110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
    Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
    Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
    J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the gene expression associated to amyotrophic lateral sclerosis.
    Recabarren-Leiva D; Alarcón M
    Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.
    Jimenez-Pacheco A; Franco JM; Lopez S; Gomez-Zumaquero JM; Magdalena Leal-Lasarte M; Caballero-Hernandez DE; Cejudo-Guillén M; Pozo D
    Adv Exp Med Biol; 2017; 978():255-275. PubMed ID: 28523551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of RNA processing in the pathogenesis of motor neuron degeneration.
    Bäumer D; Ansorge O; Almeida M; Talbot K
    Expert Rev Mol Med; 2010 Jul; 12():e21. PubMed ID: 20642879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylation and motor neuron degeneration.
    Schmalbach S; Petri S
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):279-84. PubMed ID: 20406183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis.
    Kikuchi H; Furuta A; Nishioka K; Suzuki SO; Nakabeppu Y; Iwaki T
    Acta Neuropathol; 2002 Apr; 103(4):408-14. PubMed ID: 11904761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.